PYPD · Healthcare · $101M
Pre-market $5.290.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 463 Biotechnology peers
“이번 분기는 단순한 임상 진전이 아니라 FDA가 D-PLEX100 허가 신청을 예상보다 일찍 접수하고 우선심사까지 부여한 전환점이에요.”
In the company's words · 2026 2분기 earnings call